Business Insider14d
Helicore Biopharma Emerges from Stealth to Continue Advancing Portfolio of First-in-Class GIP Antagonists for Obesity and Related Conditions
Furthermore, unlike receptor-focused GIPR antagonists, HCR-188 binds circulating GIP ligand, which is expressed exclusively by K cells in the small intestine. In contrast, GIPR is expressed throughout ...
Hosted on MSN1mon
SA Asks: Which Big Pharmas are likely to announce big M&A deals?
As far as the GIPR antagonist drug goes, PF-07976016 is still only in phase 2 clinical development. Thus, it's my belief that if this Big Pharma wants to compete in this space, it's likely going ...
Terns Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(C)(4)
The Company granted options to purchase 250,000 shares of Terns common stock to the new employee. The options have a 10-year term and an exercise price per share equal to $4.46, which was the closing ...
Seeking Alpha13d
GIPR Generation Income Properties, Inc.
View Generation Income Properties, Inc. (GIPR) current and estimated P/E ratio data provided by Seeking Alpha.
Morningstar14d
Helicore Biopharma Emerges from Stealth to Continue Advancing Portfolio of First-in-Class GIP Antagonists for Obesity and Related Conditions
Furthermore, unlike receptor-focused GIPR antagonists, HCR-188 binds circulating GIP ligand, which is expressed exclusively by K cells in the small intestine. In contrast, GIPR is expressed ...
Morningstar7d
Terns Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(C)(4)
prioritizing a GIPR antagonist nomination candidate. For more information, please visit: www.ternspharma.com. Plus, tired of market noise? The hosts of The Morning Filter explain how their new ...